Information about Trastuzumab

Trastuzumab uses

Trastuzumab is used in the treatment of breast cancer and stomach cancer.

How trastuzumab works

Trastuzumab is a monoclonal antibody specifically designed to target HER2 receptors on breast cancer cells. It flags the cancer cells for destruction by the body's immune system.

Common side effects of trastuzumab

Nausea, Headache, Rash, Reduced blood platelets, Congestive cardiac failure, Insomnia (difficulty in sleeping), Infection, Upper respiratory tract infection, Nasopharyngitis, Fatigue, Fever, Anemia, Chills, Diarrhoea, Cough, Weight loss, Altered taste, Mucosal inflammation, Decreased white blood cell count (neutrophils), Stomatitis (Inflammation of the mouth).

Available Medicine for Trastuzumab

  • ₹20263 to ₹64999
    Zydus Cadila
    2 variant(s)
  • ₹58602
    Emcure Pharmaceuticals Ltd
    1 variant(s)
  • ₹19500 to ₹57500
    2 variant(s)
  • ₹17687 to ₹57500
    Mylan Pharmaceuticals Pvt Ltd
    2 variant(s)
  • ₹58602
    Roche Products India Pvt Ltd
    1 variant(s)
  • ₹22000 to ₹58602
    Reliance Life Sciences
    2 variant(s)

Expert advice for Trastuzumab

  • Take extreme care while taking trastuzumab as it can cause heart failure, especially if you have heart disease or if you are also receiving certain other cancer medicines.
  • You may need to undergo biopsy test during trastuzumab treatment to check the effect of trastuzumab.
  • Do not drive or operate machinery as trastuzumab may cause fever or chills.
  • Tell your doctor if you are or planning to become pregnant or are breastfeeding.

Frequently asked questions for Trastuzumab


Q. Is trastuzumab a hazardous drug?
Yes, Trastuzumab is a hazardous drug and is supposed to be administered under medical supervision only.
Q. Is trastuzumab cytotoxic?
Yes, Trastuzumab is cytotoxic

Content on this page was last updated on 26 April, 2017, by Dr. Varun Gupta (MD Pharmacology)